Transfection of MDA-MB-231 human breast carcinoma cells with bone sialoprotein (BSP) stimulates migration and invasion in vitro and growth of primary and secondary tumors in nude mice

Clinical and Experimental Metastasis

Volumn 21, Issue 1, 2004, Pages 19-29

  Sharp, Julie A ^a,b   Waltham, Mark ^a,b   Williams, Elizabeth D ^c   Henderson, Michael A ^a   Thompson, Erik W ^a,b,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

Bone sialoprotein; Breast cancer; in vitro wound healing; Metastasis; Migration

Indexed keywords

COMPLEMENTARY DNA; MATRIGEL; SIALOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE METASTASIS; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER SIZE; CARCINOMA CELL; CONTROLLED STUDY; DNA TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; MOLECULAR CLONING; MOUSE; NONHUMAN; NUDE MOUSE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN ISOLATION; REAL TIME POLYMERASE CHAIN REACTION; SOFT TISSUE METASTASIS; STELLATE CELL; WOUND HEALING; X RAY ANALYSIS;

ANIMALS; BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; MICE, NUDE; MODELS, ANIMAL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; POLYMERASE CHAIN REACTION; SIALOGLYCOPROTEINS; TRANSFECTION;

EID: 1642407695     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CLIN.0000017167.17065.61     Document Type: Article

References (42)

1. Sharp JA, Sung V, Slavin J, et al. Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer. Lab Invest 1999; 79: 869-77.
2. Bellahcene A, Albert V, Pollina L, et al. Ectopic expression of bone sialoprotein in human thyroid cancer. Thyroid 1998; 8: 637-41.
3. Waltregny D, Bellahcene A, Van Riet I, et al. Prognostic value of bone sialoprotein expression in clinically localized human prostate cancer. J Natl Cancer Inst 1998; 90: 1000-8.
4. Bellahcene A, Maloujahmoum N, Fisher LW et al. Expression of bone sialoprotein in human lung cancer. Calcif Tissue Int 1997; 61: 183-8.
5. Bellahcene A, Van Riet I, de Greef C et al. Bone sialoprotein mRNA and protein expression in human multiple myeloma cell lines and patients. Br J Haematol 2000; 111: 1118-21.
6. Bellahcene A, Menard S, Bufalino R, et al. Expression of bone sialoprotein in primary human breast cancer is associated with poor survival. Int J Cancer 1996; 69: 350-3.
7. Bellahcene A, Kroll M, Liebens F, et al. Bone sialoprotein expression in primary human breast cancer is associated with bone metastases development. J Bone Miner Res 1996; 11: 665-70.
8. Diel IJ. Prognostic factors for skeletal relapse in breast cancer. Cancer Treat Rev 2001; 27: 153-7; discussion 59-64.
9. Diel IJ, Solomayer EF, Seibel MJ et al. Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis. Clin Cancer Res 1999; 5: 3914-9.
10. Fedarko NS, Jain A, Karadag A et al. Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res 2001; 7: 4060-6.
11. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 1991; 64: 327-36.
12. Sung V, Stubbs 3rd JT, Fisher L et al. Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins. J Cell Physiol 1998; 176: 482-94.
13. Bellahcene A, Bonjean K, Fohr B et al. Bone sialoprotein mediates human endothelial cell attachment and migration and promotes angiogenesis. Circ Res 2000; 86: 885-91.
14. Colleoni M, O'Neill A, Goldhirsch A et al. Identifying breast cancer patients at high risk for bone metastases. J Clin Oncol 2000; 18: 3925-35.
15. Yoneda T. Cellular and molecular basis of preferential metastasis of breast cancer to bone. J Orthop Sci 2000; 5: 75-81.
16. Martin TJ, Moseley JM. Mechanisms in the skeletal complications of breast cancer. Endocr Relat Cancer 2000; 7: 271-84.
17. Brunner N, Thompson EW, Spang-Thomsen M et al. LacZ transduced human breast cancer xenografts as an in vivo model for the study of invasion and metastasis. Eur J Cancer 1992; 28A: 1989-95.
18. Fisher LW, McBride OW, Termine JD et al. Human bone sialoprotein. deduced protein sequence and chromosomal localization. J Biol Chem 1990; 265: 2347-51.
19. Miller DL, el-Ashry D, Cheville AL, et al. Emergence of MCF-7 cells overexpressing a transfected epidermal growth factor receptor (EGFR) under estrogen-depleted conditions: evidence for a role of EGFR in breast cancer growth and progression. Cell Growth Differ 1994; 5: 1263-74.
20. Fisher LW, Stubbs J, Young MF. Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Orthop Scand 1995; 266: 61-5.
21. Thompson EW, Brunner N, Torri J et al. The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells. Clin Exp Metastasis 1993; 11: 15-26.
22. Skehan P, Storeng R, Scudiero D et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990; 82: 1107-12.
23. Price JT, Thompson EW. Models for studying cellular invasion of basement membranes. Meth Mol Biol 1999; 129: 231-49.
24. Tester AM, Ruangpanit N, Anderson RL et al. MMP-9 secretion and MMP-2 activation distinguish invasive and metastatic sublines of a mouse mammary carcinoma system showing epithelio-mesenchymal transition traits. Clin Exp Metastasis 2001; 18: 553-60.
25. Yu M, Sato H, Seiki M et al. Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells. Cancer Res 1995; 55: 3272-7.
26. Price JE, Polyzos A, Zhang RD et al. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 1990; 50: 717-21.
27. Arguello F, Baggs RB, Frantz CN. A murine model of experimental metastasis to bone and bone marrow. Cancer Res 1988; 48: 6876-81.
28. Sung V, Cattell DA, Bueno JM et al. Human breast cancer cell metastasis to long bone and soft organs of nude mice: A quantitative assay Clin Exp Metastesis 1997; 15: 173-83. [published erratum appears in Clin Exp Metastasis 1997; 15(5): 553].
29. Tester A, Sharp JA, Dhanesuan N et al. Correlation between extent of osteolytic damage and metastatic burden of human breast cancer metastasis in nude mice: Real-time PCR quantitation. Clin Exp Metast 2002; 19: 377-83.
30. Bellahcene A, Castronovo V. Expression of bone matrix proteins in human breast cancer: Potential roles in microcalcification formation and in the genesis of bone metastases. Bull Cancer 1997; 84: 17-24.
31. Gillespie MT, Thomas RJ, Pu ZY et al. Calcitonin receptors, bone sialoprotein and osteopontin are expressed in primary breast cancers. Int J Cancer 1997; 73: 812-5.
32. Ibrahim T, Leong I, Sanchez-Sweatman O et al. Expression of bone sialoprotein and osteopontin in breast cancer bone metastases. Clin Exp Metastasis 2000; 18: 253-60.
33. Ronot X, Doisy A, Tracqui P. Quantitative study of dynamic behavior of cell monolayers during in vitro wound healing by optical flow analysis. Cytometry 2000; 41: 19-30.
34. Thompson EW, Paik S, Brunner N et al. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 1992; 150: 534-44.
35. Stetler-Stevenson WG. Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 1990; 9: 289-303.
36. Pulyaeva H, Bueno J, Polette M et al. MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells. Clin Exp Metastasis 1997; 15: 111-20.
37. Teti A, Farina AR, Villanova I et al. Activation of MMP-2 by human GCT23 giant cell tumour cells induced by osteopontin, bone sialoprotein and GRGDSP peptides is RGD and cell shape change dependent. Int J Cancer 1998; 77: 82-93.
38. Guise TA, Yin JJ, Taylor SD et al. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Invest 1996; 98: 1544-9.
39. Partin AW, Schoeniger JS, Mohler JL et al. Fourier analysis of cell motility: Correlation of motility with metastatic potential. Proc Natl Acad Sci USA 1989; 86: 1254-8.
40. Raynal C, Delmas PD, Chenu C. Bone sialoprotein stimulates in vitro bone resorption. Endocrinology 1996; 137: 2347-54.
41. Oldberg A, Franzen A, Heinegard D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an arg-gly-asp cell-binding sequence. Proc Natl Acad Sci USA 1986; 83: 8819-23.
42. van der Pluijm G, Vloedgraven HJ, Ivanov B et al. Bone sialoprotein peptides are potent inhibitors of breast cancer cell adhesion to bone. Cancer Res 1996; 56: 1948-55.